#9500
Leishmania infantum IgG ELISA
ELISA kit for the diagnosis of human and canine visceral
leishmanioses
Lot 2516L (Expiry date: 03.02.2027)
Production date : 04.06.2025
Results of quality control 1 (after
production), date: 10.06.2025
No serum blank (average) : 0.134
Sample |
Absorbances of individual wells after blank reduction |
Average |
% pos. |
No serum blank
|
-0.002 |
0.002 |
0.000 |
0.001 |
0.000 |
0 |
Negative control serum
(N° 9500-06) |
0.053 |
0.057 |
0.046 |
0.054 |
0.052 |
2 |
Weak positive serum
(N° 9500-07) |
0.550 |
0.538 |
0.529 |
0.564 |
0.545 |
25 |
Positive control serum
(N° 9500-08) |
2.156 |
2.169 |
2.168 |
2.344 |
2.209 |
100 |
Validation criteria:
|
Criterion |
Measure |
Valid |
Absorbance of positive serum 9500-08 |
> 1.200 |
2.209 |
Yes |
Absorbance of weak positive serum 9500-07, as % of positive serum
|
> 10 %
|
25 % |
Yes |
Absorbance of negative serum 9500-06, as % of positive serum |
< 8 % |
2 % |
Yes |
Absorbance of no serum blank |
< 0.350 |
0.134 |
Yes |
Comments:
Good for use.
Bordier Affinity Products SA, Chatanerie 2,
Bātiment Biokema,
CH-1023 Crissier, Switzerland
Phone: + 41 21 633 31 67. Fax: +
41 21 633 31 78. Email: cb(at)bordier.ch
|